Global Bio-Pharma Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Publisher Name :
Date: 04-Jan-2024
No. of pages: 118

Market Overview of Global Bio-Pharma market:

According to our latest research, the global Bio-Pharma market looks promising in the next 5 years. As of 2022, the global Bio-Pharma market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.

This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Bio-Pharma market, with a systematical description of the status quo and trends of the whole market, a close look into the competitive landscape of the major players, and a detailed elaboration on segment markets by type, by application and by region.

Key Takeaways from the Global Bio-Pharma Market Report:

Market Size Estimates: Bio-Pharma market size estimation in terms of value and sales volume from 2018-2028

Market Trends and Dynamics: Bio-Pharma market drivers, opportunities, challenges, and risks

Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the Bio-Pharma market

Segment Market Analysis: Bio-Pharma market value and sales volume by type and by application from 2018-2028

Regional Market Analysis: Bio-Pharma market situations and prospects in North America, Asia Pacific, Europe, Latin America, Middle East, Africa

Country-level Studies on the Bio-Pharma Market: Revenue and sales volume of major countries in each region

Bio-Pharma Market Competitive Landscape and Major Players: Analysis of 10-15 leading market players, sales, price, revenue, gross, gross margin, product profile and application, etc.

Trade Flow: Import and export volume of the Bio-Pharma market in major regions.

Bio-Pharma Industry Value Chain: Bio-Pharma market raw materials & suppliers, manufacturing process, distributors, downstream customers

Bio-Pharma Industry News, Policies & Regulations

Key players in the global Bio-Pharma market are covered in Chapter 12:

AbbVie

AstraZeneca PLC

Bristol-Myers Squibb Company

Eli Lilly and Company

Biogen Idec

Merck & Co., Inc

Pfizer

Sanofi, Amgen

Johnson & Johnson Services

Bayer AG

Abbott Laboratories

F. Hoffmann-La Roche AG

Novartis AG GlaxoSmithKline Plc

In Chapter 2 and Chapter 15.1, based on types, the Bio-Pharma market from 2018 to 2028 is primarily split into:

Monoclonal Antibodies

Recombinant Proteins

Granulocyte-Colony Stimulating Factor (G-CSF)

Interferons

Recombinant Human Insulin

Erythropoietin

Vaccines

Growth Hormones

Purified Proteins

Others

In Chapter 3 and Chapter 15.2, based on applications, the Bio-Pharma market from 2018 to 2028 covers:

Metabolic Disorders

Oncology

Neurological Disorders

Cardiovascular Diseases

Inflammatory and Infectious Diseases

Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 7, 8, 9, 10, 11, 15.3, 15.4:

North America (Covered in Chapter 7)

United States

Canada

Asia-Pacific (Covered in Chapter 8)

China

Japan

India

South Korea

Southeast Asia

Australia

Others

Europe (Covered in Chapter 9)

Germany

France

UK

Italy

Spain

Russia

Poland

Others

Latin America (Covered in Chapter 10)

Mexico

Brazil

Argentina

Others

Middle East and Africa (Covered in Chapter 11)

GCC Countries

Africa

Others

The data of this research report is mainly obtained from industry associations, magazines, press releases, national customs, annual reports of enterprises, expert interviews, paid databases and other channels with authority. It also provides scientific forecasts of the industry's core development indicators through professional analysis and forecasting models.

In short, whatever role you take in this industry value chain, this report will help you or your company to acquire a systematic and in-depth understanding of the industry.

Chapter Outline

This report consists of 16 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:

Chapter 1 starts the report with an overview of the Bio-Pharma market, as well as the definitions of the target market and the subdivisions. Through the presented global market size, regional market sizes, and segment market shares, you will be able to draw an overall and comprehensive picture of the market situation. Meanwhile, the research method and data source will be shared in this chapter.

Chapter 2 and Chapter 3 breaks down the market by different types and applications, with historic data presented in metrics of sales volume, revenue, market share and growth rate.

Chapter 4 elaborates on market dynamics and future trends in the industry, which contains an in-depth analysis of market drivers, opportunities, challenges, and risks. Other essential factors that will have a major impact on the market, i.e., industry news and policies in recent years, global inflation, and regional conflict, are also taken into consideration.

Chapter 5 compares the sales volume and revenue of the major regions across the globe, which enables the readers to understand the regional competitive pattern.

Chapter 6 is the analysis of the trade flow. Import volume and export volume are revealed on a regional level.

Chapters 7-11 focus on country-level studies. Data from the major countries in each region are provided, showing the current development of the industry in different countries. Besides, you will also find qualitative trends analysis under global inflation under each of the 6 regions.

Chapter 12 first up presents the competitive landscape by displaying and comparing the revenues, sales volumes, and market shares of the top players in the market, followed by a company-by-company analysis of all the major market participants with introductions of their products, product applications, company profiles, and business overview. In addition, their competitiveness is manifested through numbers of sales volume, revenue, price, gross and gross margin.

Chapter 13 looks into the whole market industrial chain, ranging from the upstream key raw materials and their suppliers to midstream distributors and downstream customers, with influences of global inflation taken into consideration.

Chapter 14 is perfect for those who wish to develop new projects in the industry. This chapter sheds a light on industry entry barriers and gives suggestions on new project investments.

Chapter 15 forecasts the future trend of the market from the perspective of different types, applications, and major regions.

Chapter 16 is the conclusion of the report which helps the readers sum up the main findings and insights.

Years considered for this report:

Historical Years: 2018-2022

Base Year: 2022

Estimated Year: 2023

Forecast Period: 2023-2028

Global Bio-Pharma Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Table of Content

1 Bio-Pharma Market Overview
1.1 Product Overview
1.2 Market Segmentation
1.2.1 Market by Types
1.2.2 Market by Applications
1.2.3 Market by Regions
1.3 Global Bio-Pharma Market Size (2018-2028)
1.3.1 Global Bio-Pharma Revenue ($) and Growth Rate (2018-2028)
1.3.2 Global Bio-Pharma Sales Volume and Growth Rate (2018-2028)
1.4 Research Method and Logic
1.4.1 Research Method
1.4.2 Research Data Source

2 Global Bio-Pharma Market Historic Revenue ($) and Sales Volume Segment by Type
2.1 Global Bio-Pharma Historic Revenue ($) by Type (2018-2023)
2.2 Global Bio-Pharma Historic Sales Volume by Type (2018-2023)
2.3 Monoclonal Antibodies Sales and Price (2018-2023)
2.4 Recombinant Proteins Sales and Price (2018-2023)
2.5 Granulocyte-Colony Stimulating Factor (G-CSF) Sales and Price (2018-2023)
2.6 Interferons Sales and Price (2018-2023)
2.7 Recombinant Human Insulin Sales and Price (2018-2023)
2.8 Erythropoietin Sales and Price (2018-2023)
2.9 Vaccines Sales and Price (2018-2023)
2.10 Growth Hormones Sales and Price (2018-2023)
2.11 Purified Proteins Sales and Price (2018-2023)
2.12 Others Sales and Price (2018-2023)

3 Global Bio-Pharma Historic Revenue ($) and Sales Volume by Application (2018-2023)
3.1 Global Bio-Pharma Historic Revenue ($) by Application (2018-2023)
3.2 Global Bio-Pharma Historic Sales Volume by Application (2018-2023)
3.3 Metabolic Disorders Sales, Revenue and Growth Rate (2018-2023)
3.4 Oncology Sales, Revenue and Growth Rate (2018-2023)
3.5 Neurological Disorders Sales, Revenue and Growth Rate (2018-2023)
3.6 Cardiovascular Diseases Sales, Revenue and Growth Rate (2018-2023)
3.7 Inflammatory and Infectious Diseases Sales, Revenue and Growth Rate (2018-2023)
3.8 Others Sales, Revenue and Growth Rate (2018-2023)

4 Market Dynamic and Trends
4.1 Industry Development Trends under Global Inflation
4.2 Impact of Russia and Ukraine War
4.3 Driving Factors for Bio-Pharma Market
4.4 Factors Challenging the Market
4.5 Opportunities
4.6 Risk Analysis
4.7 Industry News and Policies by Regions
4.7.1 Bio-Pharma Industry News
4.7.2 Bio-Pharma Industry Policies

5 Global Bio-Pharma Market Revenue ($) and Sales Volume by Major Regions
5.1 Global Bio-Pharma Sales Volume by Region (2018-2023)
5.2 Global Bio-Pharma Market Revenue ($) by Region (2018-2023)

6 Global Bio-Pharma Import Volume and Export Volume by Major Regions
6.1 Global Bio-Pharma Import Volume by Region (2018-2023)
6.2 Global Bio-Pharma Export Volume by Region (2018-2023)

7 North America Bio-Pharma Market Current Status (2018-2023)
7.1 Overall Market Size Analysis (2018-2023)
7.1.1 North America Bio-Pharma Revenue ($) and Growth Rate (2018-2023)
7.1.2 North America Bio-Pharma Sales Volume and Growth Rate (2018-2023)
7.2 North America Bio-Pharma Market Trends Analysis Under Global Inflation
7.3 North America Bio-Pharma Sales Volume and Revenue ($) by Country (2018-2023)
7.4 United States
7.4.1 United States Bio-Pharma Revenue ($) and Growth Rate (2018-2023)
7.5 Canada
7.5.1 Canada Bio-Pharma Revenue ($) and Growth Rate (2018-2023)

8 Asia Pacific Bio-Pharma Market Current Status (2018-2023)
8.1 Overall Market Size Analysis (2018-2023)
8.1.1 Asia Pacific Bio-Pharma Revenue ($) and Growth Rate (2018-2023)
8.1.2 Asia Pacific Bio-Pharma Sales Volume and Growth Rate (2018-2023)
8.2 Asia Pacific Bio-Pharma Market Trends Analysis Under Global Inflation
8.3 Asia Pacific Bio-Pharma Sales Volume and Revenue ($) by Country (2018-2023)
8.4 China
8.4.1 China Bio-Pharma Revenue ($) and Growth Rate (2018-2023)
8.5 Japan
8.5.1 Japan Bio-Pharma Revenue ($) and Growth Rate (2018-2023)
8.6 India
8.6.1 India Bio-Pharma Revenue ($) and Growth Rate (2018-2023)
8.7 South Korea
8.7.1 South Korea Bio-Pharma Revenue ($) and Growth Rate (2018-2023)
8.8 Southeast Asia
8.8.1 Southeast Asia Bio-Pharma Revenue ($) by Country (2018-2023)
8.9 Australia
8.9.1 Australia Bio-Pharma Revenue ($) and Growth Rate (2018-2023)

9 Europe Bio-Pharma Market Current Status (2018-2023)
9.1 Overall Market Size Analysis (2018-2023)
9.1.1 Europe Bio-Pharma Revenue ($) and Growth Rate (2018-2023)
9.2.1 Europe Bio-Pharma Sales Volume and Growth Rate (2018-2023)
9.2 Europe Bio-Pharma Market Trends Analysis Under Global Inflation
9.3 Europe Bio-Pharma Sales Volume and Revenue ($) by Country (2018-2023)
9.4 Germany
9.4.1 Germany Bio-Pharma Revenue ($) and Growth Rate (2018-2023)
9.5 France
9.5.1 France Bio-Pharma Revenue ($) and Growth Rate (2018-2023)
9.6 United Kingdom
9.6.1 United Kingdom Bio-Pharma Revenue ($) and Growth Rate (2018-2023)
9.7 Italy
9.7.1 Italy Bio-Pharma Revenue ($) and Growth Rate (2018-2023)
9.8 Spain
9.8.1 Spain Bio-Pharma Revenue ($) and Growth Rate (2018-2023)
9.9 Russia
9.9.1 Russia Bio-Pharma Revenue ($) and Growth Rate (2018-2023)
9.10 Poland
9.10.1 Poland Bio-Pharma Revenue ($) and Growth Rate (2018-2023)

10 Latin America Bio-Pharma Market Current Status (2018-2023)
10.1 Overall Market Size Analysis (2018-2023)
10.1.1 Latin America Bio-Pharma Revenue ($) and Growth Rate (2018-2023)
10.1.2 Latin America Bio-Pharma Sales Volume and Growth Rate (2018-2023)
10.2 Latin America Bio-Pharma Market Trends Analysis Under Global Inflation
10.3 Latin America Bio-Pharma Sales Volume and Revenue ($) by Country (2018-2023)
10.4 Mexico
10.4.1 Mexico Bio-Pharma Revenue ($) and Growth Rate (2018-2023)
10.5 Brazil
10.5.1 Brazil Bio-Pharma Revenue ($) and Growth Rate (2018-2023)
10.6 Argentina
10.6.1 Argentina Bio-Pharma Revenue ($) and Growth Rate (2018-2023)

11 Middle East and Africa Bio-Pharma Market Current Status (2018-2023)
11.1 Overall Market Size Analysis (2018-2023)
11.1.1 Middle East and Africa Bio-Pharma Revenue ($) and Growth Rate (2018-2023)
11.2.1 Middle East and Africa Bio-Pharma Sales Volume and Growth Rate (2018-2023)
11.2 Middle East and Africa Bio-Pharma Market Trends Analysis Under Global Inflation
11.3 Middle East and Africa Bio-Pharma Sales Volume and Revenue ($) by Country (2018-2023)
11.4 GCC Countries
11.4.1 GCC Countries Bio-Pharma Revenue ($) and Growth Rate (2018-2023)
11.5 Africa
11.5.1 Africa Bio-Pharma Revenue ($) and Growth Rate (2018-2023)

12 Market Competition Analysis and Key Companies Profiles
12.1 Market Competition by Key Players
12.1.1 Global Bio-Pharma Revenue ($) and Market Share of Key Players
12.1.2 Global Bio-Pharma Sales Volume and Market Share of Key Players
12.1.3 Global Bio-Pharma Average Price by Players
12.1.4 Mergers & Acquisitions, Expansion
12.2 AbbVie Market Performance and Business Analysis
12.2.1 Company Profiles
12.2.2 Product Profiles and Application
12.2.3 AbbVie Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.3 AstraZeneca PLC Market Performance and Business Analysis
12.3.1 Company Profiles
12.3.2 Product Profiles and Application
12.3.3 AstraZeneca PLC Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.4 Bristol-Myers Squibb Company Market Performance and Business Analysis
12.4.1 Company Profiles
12.4.2 Product Profiles and Application
12.4.3 Bristol-Myers Squibb Company Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.5 Eli Lilly and Company Market Performance and Business Analysis
12.5.1 Company Profiles
12.5.2 Product Profiles and Application
12.5.3 Eli Lilly and Company Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.6 Biogen Idec Market Performance and Business Analysis
12.6.1 Company Profiles
12.6.2 Product Profiles and Application
12.6.3 Biogen Idec Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.7 Merck & Co., Inc Market Performance and Business Analysis
12.7.1 Company Profiles
12.7.2 Product Profiles and Application
12.7.3 Merck & Co., Inc Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.8 Pfizer Market Performance and Business Analysis
12.8.1 Company Profiles
12.8.2 Product Profiles and Application
12.8.3 Pfizer Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.9 Sanofi, Amgen Market Performance and Business Analysis
12.9.1 Company Profiles
12.9.2 Product Profiles and Application
12.9.3 Sanofi, Amgen Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.10 Johnson & Johnson Services Market Performance and Business Analysis
12.10.1 Company Profiles
12.10.2 Product Profiles and Application
12.10.3 Johnson & Johnson Services Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.11 Bayer AG Market Performance and Business Analysis
12.11.1 Company Profiles
12.11.2 Product Profiles and Application
12.11.3 Bayer AG Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.12 Abbott Laboratories Market Performance and Business Analysis
12.12.1 Company Profiles
12.12.2 Product Profiles and Application
12.12.3 Abbott Laboratories Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.13 F. Hoffmann-La Roche AG Market Performance and Business Analysis
12.13.1 Company Profiles
12.13.2 Product Profiles and Application
12.13.3 F. Hoffmann-La Roche AG Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.14 Novartis AG GlaxoSmithKline Plc Market Performance and Business Analysis
12.14.1 Company Profiles
12.14.2 Product Profiles and Application
12.14.3 Novartis AG GlaxoSmithKline Plc Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)

13 Value Chain of the Bio-Pharma Market
13.1 Value Chain Status
13.1.1 Value Chain Status Under Global Inflation
13.2 Key Raw Materials and Suppliers
13.2.1 Key Raw Materials Introduction
13.2.2 Key Suppliers of Raw Materials
13.3 Manufacturing Cost Structure Analysis
13.3.1 Production Process Analysis
13.3.2 Manufacturing Cost Structure of Bio-Pharma
13.3.3 Raw Material Cost of Bio-Pharma
13.3.4 Labor Cost of Bio-Pharma
13.4 Major Distributors by Region
13.5 Customer Analysis

14 New Project Feasibility Analysis
14.1 Industry Barriers and New Entrants SWOT Analysis
14.2 Analysis and Suggestions on New Project Investment

15 Global Bio-Pharma Market Revenue ($) and Sales Volume Forecast Segment by Type, Application and Region
15.1 Global Bio-Pharma Revenue ($) and Sales Volume Forecast by Type (2023-2028)
15.1.1 Global Bio-Pharma Revenue ($) Forecast by Type (2023-2028)
15.1.2 Global Bio-Pharma Sales Volume Forecast by Type (2023-2028)
15.2 Global Bio-Pharma Revenue ($) and Sales Volume Forecast by Application (2023-2028)
15.2.1 Global Bio-Pharma Revenue ($) Forecast by Application (2023-2028)
15.2.2 Global Bio-Pharma Sales Volume Forecast by Application (2023-2028)
15.3 Global Bio-Pharma Sales Volume Forecast by Region (2023-2028)
15.4 Global Bio-Pharma Revenue ($) Forecast by Region (2023-2028)

16 Research Findings and Conclusion

List of Tables and Figures

Figure Bio-Pharma Picture
Table Bio-Pharma Definition
Table Description and Definitions
Figure Monoclonal Antibodies Features
Figure Recombinant Proteins Features
Figure Granulocyte-Colony Stimulating Factor (G-CSF) Features
Figure Interferons Features
Figure Recombinant Human Insulin Features
Figure Erythropoietin Features
Figure Vaccines Features
Figure Growth Hormones Features
Figure Purified Proteins Features
Figure Others Features
Table Description and Definitions
Figure Metabolic Disorders
Figure Oncology
Figure Neurological Disorders
Figure Cardiovascular Diseases
Figure Inflammatory and Infectious Diseases
Figure Others
Figure North America Bio-Pharma Revenue ($) and Growth Rate (2018-2028)
Figure Asia Pacific Bio-Pharma Revenue ($) and Growth Rate (2018-2028)
Figure Europe Bio-Pharma Revenue ($) and Growth Rate (2018-2028)
Figure Latin America Bio-Pharma Revenue ($) and Growth Rate (2018-2028)
Figure Middle East and Africa Bio-Pharma Revenue ($) and Growth Rate (2018-2028)
Figure Global Bio-Pharma Revenue ($) and Growth Rate (2018-2028)
Figure Global Bio-Pharma Sales Volume and Growth Rate (2018-2028)
Table Global Bio-Pharma Historic Revenue ($) by Type (2018-2023) (Million USD)
Table Global Bio-Pharma Historic Revenue ($) Share by Type (2018-2023)
Table Global Bio-Pharma Historic Sales Volume by Type (2018-2023)
Table Global Bio-Pharma Historic Sales Volume Share by Type (2018-2023)
Figure Global Monoclonal Antibodies Sales and Growth Rate (2018-2023)
Figure Global Monoclonal Antibodies Price (2018-2023)
Figure Global Recombinant Proteins Sales and Growth Rate (2018-2023)
Figure Global Recombinant Proteins Price (2018-2023)
Figure Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales and Growth Rate (2018-2023)
Figure Global Granulocyte-Colony Stimulating Factor (G-CSF) Price (2018-2023)
Figure Global Interferons Sales and Growth Rate (2018-2023)
Figure Global Interferons Price (2018-2023)
Figure Global Recombinant Human Insulin Sales and Growth Rate (2018-2023)
Figure Global Recombinant Human Insulin Price (2018-2023)
Figure Global Erythropoietin Sales and Growth Rate (2018-2023)
Figure Global Erythropoietin Price (2018-2023)
Figure Global Vaccines Sales and Growth Rate (2018-2023)
Figure Global Vaccines Price (2018-2023)
Figure Global Growth Hormones Sales and Growth Rate (2018-2023)
Figure Global Growth Hormones Price (2018-2023)
Figure Global Purified Proteins Sales and Growth Rate (2018-2023)
Figure Global Purified Proteins Price (2018-2023)
Figure Global Others Sales and Growth Rate (2018-2023)
Figure Global Others Price (2018-2023)
Table Global Bio-Pharma Historic Revenue ($) by Application (2018-2023) (Million USD)
Table Global Bio-Pharma Historic Revenue ($) Share by Application (2018-2023)
Table Global Bio-Pharma Historic Sales Volume by Application (2018-2023) (Million USD)
Table Global Bio-Pharma Historic Sales Volume Share by Application (2018-2023)
Figure Global Metabolic Disorders Sales and Growth Rate (2018-2023)
Figure Global Metabolic Disorders Revenue and Growth Rate (2018-2023)
Figure Global Oncology Sales and Growth Rate (2018-2023)
Figure Global Oncology Revenue and Growth Rate (2018-2023)
Figure Global Neurological Disorders Sales and Growth Rate (2018-2023)
Figure Global Neurological Disorders Revenue and Growth Rate (2018-2023)
Figure Global Cardiovascular Diseases Sales and Growth Rate (2018-2023)
Figure Global Cardiovascular Diseases Revenue and Growth Rate (2018-2023)
Figure Global Inflammatory and Infectious Diseases Sales and Growth Rate (2018-2023)
Figure Global Inflammatory and Infectious Diseases Revenue and Growth Rate (2018-2023)
Figure Global Others Sales and Growth Rate (2018-2023)
Figure Global Others Revenue and Growth Rate (2018-2023)
Table Industry Development Trends under Global Inflation
Table Impact of Russia and Ukraine War
Table Driving Factors for Bio-Pharma Market
Table Factors Challenging the Market
Table Opportunities
Table Risk Analysis
Table Industry News by Regions
Table Industry Policies by Regions
Table Global Bio-Pharma Sales Volume by Region (2018-2023)
Table Global Bio-Pharma Sales Volume Share by Region (2018-2023)
Table Global Bio-Pharma Market Revenue ($) by Region (2018-2023)
Table Global Bio-Pharma Market Revenue ($) Share by Region (2018-2023)
Table Global Bio-Pharma Import Volume by Region (2018-2023)
Table Global Bio-Pharma Export Volume by Region (2018-2023)
Figure North America Bio-Pharma Revenue ($) and Growth Rate (2018-2023)
Figure North America Bio-Pharma Sales Volume and Growth Rate (2018-2023)
Table North America Bio-Pharma Market Trends Analysis Under Global Inflation
Table North America Bio-Pharma Revenue ($) by Country (2018-2023)
Table North America Bio-Pharma Sales Volume by Country (2018-2023)
Figure United States Bio-Pharma Revenue ($) and Growth Rate (2018-2023)
Figure Canada Bio-Pharma Revenue ($) and Growth Rate (2018-2023)
Figure Asia Pacific Bio-Pharma Revenue ($) and Growth Rate (2018-2023)
Figure Asia Pacific Bio-Pharma Sales Volume and Growth Rate (2018-2023)
Table Asia Pacific Bio-Pharma Market Trends Analysis Under Global Inflation
Table Asia Pacific Bio-Pharma Revenue ($) by Country (2018-2023)
Table Asia Pacific Bio-Pharma Sales Volume by Country (2018-2023)
Figure China Bio-Pharma Revenue ($) and Growth Rate (2018-2023)
Figure Japan Bio-Pharma Revenue ($) and Growth Rate (2018-2023)
Figure India Bio-Pharma Revenue ($) and Growth Rate (2018-2023)
Figure South Korea Bio-Pharma Revenue ($) and Growth Rate (2018-2023)
Table Southeast Asia Bio-Pharma Revenue ($) by Country (2018-2023)
Figure Australia Bio-Pharma Revenue ($) and Growth Rate (2018-2023)
Figure Europe Bio-Pharma Revenue ($) and Growth Rate (2018-2023)
Figure Europe Bio-Pharma Sales Volume and Growth Rate (2018-2023)
Table Europe Bio-Pharma Market Trends Analysis Under Global Inflation
Table Europe Bio-Pharma Revenue ($) by Country (2018-2023)
Table Europe Bio-Pharma Sales Volume by Country (2018-2023)
Figure Germany Bio-Pharma Revenue ($) and Growth Rate (2018-2023)
Figure France Bio-Pharma Revenue ($) and Growth Rate (2018-2023)
Figure United Kingdom Bio-Pharma Revenue ($) and Growth Rate (2018-2023)
Figure Italy Bio-Pharma Revenue ($) and Growth Rate (2018-2023)
Figure Spain Bio-Pharma Revenue ($) and Growth Rate (2018-2023)
Figure Russia Bio-Pharma Revenue ($) and Growth Rate (2018-2023)
Figure Poland Bio-Pharma Revenue ($) and Growth Rate (2018-2023)
Figure Latin America Bio-Pharma Revenue ($) and Growth Rate (2018-2023)
Figure Latin America Bio-Pharma Sales Volume and Growth Rate (2018-2023)
Table Latin America Bio-Pharma Market Trends Analysis Under Global Inflation
Table Latin America Bio-Pharma Revenue ($) by Country (2018-2023)
Table Latin America Bio-Pharma Sales Volume by Country (2018-2023)
Figure Mexico Bio-Pharma Revenue ($) and Growth Rate (2018-2023)
Figure Brazil Bio-Pharma Revenue ($) and Growth Rate (2018-2023)
Figure Argentina Bio-Pharma Revenue ($) and Growth Rate (2018-2023)
Figure Middle East and Africa Bio-Pharma Revenue ($) and Growth Rate (2018-2023)
Figure Middle East and Africa Bio-Pharma Sales Volume and Growth Rate (2018-2023)
Table Middle East and Africa Bio-Pharma Market Trends Analysis Under Global Inflation
Table Middle East and Africa Bio-Pharma Revenue ($) by Country (2018-2023)
Table Middle East and Africa Bio-Pharma Sales Volume by Country (2018-2023)
Figure GCC Countries Bio-Pharma Revenue ($) and Growth Rate (2018-2023)
Figure Africa Bio-Pharma Revenue ($) and Growth Rate (2018-2023)
Table Global Bio-Pharma Revenue ($) of Key Players (2018-2023)
Table Global Bio-Pharma Revenue ($) Share of Key Players (2018-2023)
Table Global Bio-Pharma Sales Volume of Key Players (2018-2023)
Table Global Bio-Pharma Sales Volume Share of Key Players (2018-2023)
Table Global Bio-Pharma Average Price of Key Players (2018-2023)
Table Mergers & Acquisitions, Expansion Plans
Table AbbVie Company Profiles
Table Product Profiles and Application
Table AbbVie Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure AbbVie Production and Growth Rate
Figure AbbVie Value ($) Market Share 2018-2023
Table AstraZeneca PLC Company Profiles
Table Product Profiles and Application
Table AstraZeneca PLC Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure AstraZeneca PLC Production and Growth Rate
Figure AstraZeneca PLC Value ($) Market Share 2018-2023
Table Bristol-Myers Squibb Company Company Profiles
Table Product Profiles and Application
Table Bristol-Myers Squibb Company Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Bristol-Myers Squibb Company Production and Growth Rate
Figure Bristol-Myers Squibb Company Value ($) Market Share 2018-2023
Table Eli Lilly and Company Company Profiles
Table Product Profiles and Application
Table Eli Lilly and Company Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Eli Lilly and Company Production and Growth Rate
Figure Eli Lilly and Company Value ($) Market Share 2018-2023
Table Biogen Idec Company Profiles
Table Product Profiles and Application
Table Biogen Idec Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Biogen Idec Production and Growth Rate
Figure Biogen Idec Value ($) Market Share 2018-2023
Table Merck & Co., Inc Company Profiles
Table Product Profiles and Application
Table Merck & Co., Inc Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Merck & Co., Inc Production and Growth Rate
Figure Merck & Co., Inc Value ($) Market Share 2018-2023
Table Pfizer Company Profiles
Table Product Profiles and Application
Table Pfizer Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Pfizer Production and Growth Rate
Figure Pfizer Value ($) Market Share 2018-2023
Table Sanofi, Amgen Company Profiles
Table Product Profiles and Application
Table Sanofi, Amgen Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Sanofi, Amgen Production and Growth Rate
Figure Sanofi, Amgen Value ($) Market Share 2018-2023
Table Johnson & Johnson Services Company Profiles
Table Product Profiles and Application
Table Johnson & Johnson Services Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Johnson & Johnson Services Production and Growth Rate
Figure Johnson & Johnson Services Value ($) Market Share 2018-2023
Table Bayer AG Company Profiles
Table Product Profiles and Application
Table Bayer AG Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Bayer AG Production and Growth Rate
Figure Bayer AG Value ($) Market Share 2018-2023
Table Abbott Laboratories Company Profiles
Table Product Profiles and Application
Table Abbott Laboratories Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Abbott Laboratories Production and Growth Rate
Figure Abbott Laboratories Value ($) Market Share 2018-2023
Table F. Hoffmann-La Roche AG Company Profiles
Table Product Profiles and Application
Table F. Hoffmann-La Roche AG Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure F. Hoffmann-La Roche AG Production and Growth Rate
Figure F. Hoffmann-La Roche AG Value ($) Market Share 2018-2023
Table Novartis AG GlaxoSmithKline Plc Company Profiles
Table Product Profiles and Application
Table Novartis AG GlaxoSmithKline Plc Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Novartis AG GlaxoSmithKline Plc Production and Growth Rate
Figure Novartis AG GlaxoSmithKline Plc Value ($) Market Share 2018-2023
Figure Industry Chain Analysis of Bio-Pharma
Table Value Chain Status Under Global Inflation
Table Key Raw Materials Introduction
Table Upstream Raw Material Suppliers of Bio-Pharma with Contact Information
Figure Production Process of Bio-Pharma
Figure Manufacturing Cost Structure of Bio-Pharma
Table Major Distributors of Bio-Pharma with Contact Information
Table Major Downstream Buyers of Bio-Pharma with Contact Information
Figure Industry Resource/Technology/Labor Importance Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery
Table Global Bio-Pharma Revenue ($) Forecast by Type (2023-2028) (Million USD)
Table Global Bio-Pharma Revenue ($) Share Forecast by Type (2023-2028)
Table Global Bio-Pharma Sales Volume Forecast by Type (2023-2028) (Million USD)
Table Global Bio-Pharma Sales Volume Share Forecast by Type (2023-2028)
Table Global Bio-Pharma Revenue ($) Forecast by Application (2023-2028) (Million USD)
Table Global Bio-Pharma Revenue ($) Share Forecast by Application (2023-2028)
Table Global Bio-Pharma Sales Volume Forecast by Application (2023-2028) (Million USD)
Table Global Bio-Pharma Sales Volume Share Forecast by Application (2023-2028)
Table Global Bio-Pharma Sales Volume Forecast by Region (2023-2028)
Table Global Bio-Pharma Sales Volume Share Forecast by Region (2023-2028)
Table Global Bio-Pharma Revenue ($) Forecast by Region (2023-2028)
Table Global Bio-Pharma Revenue ($) Share Forecast by Region (2023-2028)
  • Global Biopharmaceuticals Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155
    According to our LPI (LP Information) latest study, the global Biopharmaceuticals market size was valued at US$ 31700 million in 2023. With growing demand in downstream market, the Biopharmaceuticals is forecast to a readjusted size of US$ 55380 million by 2030 with a CAGR of 8.3% during review period. The research report highlights the growth potential of the global Biopharmaceuticals market. Biopharmaceuticals are expected to show stable growth in the future market. However, product di......
  • Global Bio-Pharma Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 118
    Market Overview of Global Bio-Pharma market: According to our latest research, the global Bio-Pharma market looks promising in the next 5 years. As of 2022, the global Bio-Pharma market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Bio-Pharma market, with a systematical de......
  • Global Bio-pharma Market Research Report 2023
    Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 91
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Bio-pharma market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Pfizer - F. Hoffmann-La Roche AG - Johnson & Johnson Services - Sanofi, Amgen - AbbVie - Merck & Co., Inc - Biogen Idec - Bayer AG - E......
  • Continuous Bioprocessing Market by Product (Chromatography, Filtration, Bioreactor, Media), Process (Upstream, Downstream), Scale of Operation (Commercial, Clinical), Application (mAbs, Vaccines, Cell & Gene Therapy), & End User - Global Forecast to 2028
    Published: 24-Nov-2023        Price: US 4950 Onwards        Pages: 273
    “Rising demand for biopharmaceuticals and growing adoption among CDMOs and CMOs are driving the growth of the continuous bioprocessing market.” The global continuous bioprocessing market is projected to reach USD 599 million by 2028 from USD 218 million in 2023, at a CAGR of 22.4% during the forecast period of 2023 to 2028. The growth of this market can be attributed to the increasing adoption of continuous bioprocessing among CDMOs and CMOs. Continuous b......
  • Global Biopharmaceuticals Professional Survey Report 2023, Forecast to 2028
    Published: 20-Nov-2023        Price: US 3280 Onwards        Pages: 139
    A biopharmaceutical, also known as a biologic medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of em......
  • Global Biopharmaceuticals Market Research Report 2023, Forecast to 2028
    Published: 20-Nov-2023        Price: US 2680 Onwards        Pages: 160
    A biopharmaceutical, also known as a biologic medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of em......
  • 2023-2031 Report on Global Biopharmaceuticals Market by Player, Region, Type, Application and Sales Channel
    Published: 18-Sep-2023        Price: US 2500 Onwards        Pages: 85
    This report studies the Biopharmaceuticals market, covering market size for segment by type (Monoclonal Antibodies, Interferon, etc.), by application (Tumor, Diabetes, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Roche, Amgen, Abbvie, Sanofi-Aventis, Johnson & Johnson, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Biopharmaceutic......
  • Global Bio-pharma Market Insights, Forecast to 2029
    Published: 10-Aug-2023        Price: US 4900 Onwards        Pages: 108
    The global Bio-pharma market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The US & Canada market for Bio-pharma is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029. The China market for Bio-pharma is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of......
  • Biopharmaceuticals Markets in China
    Published: 24-Jul-2023        Price: US 4000 Onwards        Pages: 233
    China's demand for Biopharmaceuticals has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, indu......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs